Apimeds Pharmaceuticals US
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APUS and other ETFs, options, and stocks.About APUS
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS).
APUS Key Statistics
Stock Snapshot
The current Apimeds Pharmaceuticals US(APUS) stock price is $5.65, with a market capitalization of 85.27M. The stock trades at a price-to-earnings (P/E) ratio of -0.21.
On 2026-07-25, Apimeds Pharmaceuticals US(APUS) stock traded between a low of $5.44 and a high of $6.87. Shares are currently priced at $5.65, which is +3.9% above the low and -17.8% below the high.
Apimeds Pharmaceuticals US(APUS) shares are trading with a volume of 28.06K, against a daily average of 16.01K.
During the past year, Apimeds Pharmaceuticals US(APUS) stock moved between $5.44 at its lowest and $59.70 at its peak.
During the past year, Apimeds Pharmaceuticals US(APUS) stock moved between $5.44 at its lowest and $59.70 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.